SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-048312
Filing Date
2024-04-17
Accepted
2024-04-17 16:08:13
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-17

Document Format Files

Seq Description Document Type Size
1 ARS tm242787d4_ars.pdf ARS 4820159
  Complete submission text file 0001104659-24-048312.txt   6624685
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39264 | Film No.: 24851046
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)